Mergers and acquisitions activity in Western Europe in the pharmaceuticals sector exceeded activity in the US for the first time in four years, according to PricewaterhouseCoopers.
There were 56 deals in Western Europe, and 55 in the US, with a further eight in Eastern Europe, 25 in the Asia Pacific region and eight in the rest of the world.